Evidence map›Paper›PMID 27012661›Full record

SynthesisPediatric rheumatology online journal2016

IgG4-related disease: a systematic review of this unrecognized disease in pediatrics.

Faiz Karim, Jan Loeffen, Wichor Bramer, Lauren Westenberg, Rob Verdijk, Martin van Hagen, Jan van Laar

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Pediatric rheumatology online journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Pediatric orbital IgG4-related disease: A case series.American journal of ophthalmology case reports · 2026
    Article
  5. Article
  6. Review
  7. Observational
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Tubulointerstitial nephritis in children and adolescents.Pediatric nephrology (Berlin, Germany) · 2025
    Review
  14. Article
  15. Prevalence of Elevated IgG4 in Patients with Nasopharynx and Laryngopharynx Diseases: A Systematic Review and Meta-Analysis.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. IgG4-related disease-rare but you should not forget it.Advances in rheumatology (London, England) · 2024
    Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Faiz KarimDepartments of Internal Medicine and Immunology Erasmus MC, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. a.karim@erasmusmc.nl.
Jan LoeffenDepartment of Pediatrics Oncology, Erasmus MC-Sophia Children's hospital, Rotterdam, The Netherlands.
Wichor BramerMedical library, Erasmus MC, Rotterdam, The Netherlands.
Lauren WestenbergDepartments of Internal Medicine and Immunology Erasmus MC, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Rob VerdijkDepartment of Pathology, Erasmus MC, Rotterdam, The Netherlands.
Martin van HagenDepartments of Internal Medicine and Immunology Erasmus MC, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Jan van LaarDepartments of Internal Medicine and Immunology Erasmus MC, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Erasmus MC · NLErasmus University Rotterdam · NLErasmus MC - Sophia Children’s Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmunoglobulin G4-related disease (IgG4-RD) is a systemic fibro-inflammatory condition with an unclear pathophysiological mechanism affecting different parts of the body. If untreated, the disease can lead to fibrosis and irreversible organ damage. IgG4-RD mostly has been described in adults, hence it is generally unknown among pediatricians. This systematic search of the literature provides an overview of all reports published on IgG4-RD in children in order to create awareness of IgG4-RD in pediatrics and to emphasize the broad clinical presentation of this disease.

methodsA systematic literature search of Embase, Medline, Web-of-Science, PubMed publisher, Cochrane and Google Scholar was performed for case reports on IgG4-RD in children.

resultsOf total 740 articles identified by the search, 22 case reports including 25 cases of IgG4-RD in children were found. The median age of the children was 13 years, of which 64 % were girls. IgG4-related orbital disease (44 %) and autoimmune pancreatitis type 1/IgG4-related pancreatitis (12 %) predominantly occurred. Less frequently, other manifestations as pulmonary manifestation, cholangitis and lymphadenopathy were also found. Almost all cases were histologically proven. Prednisone was the first choice of treatment leading to favorable clinical response in 83 % of the cases. Maintenance therapy with steroid sparing agents was required in 43 % of the cases needing therapy. Rituximab was successful in all 4 cases, whereas, the disease modifying rheumatic drugs (DMARDs) mycophenolate mofetil, azathioprine and methotrexate were effective in almost 50 % of the cases.

conclusionIgG4-RD in children is a generally unknown disease among pediatricians, but several pediatric cases have been described. Prednisone is the first choice of treatment leading to disease remission in the majority of the cases. DMARDs and rituximab are alternative effective steroid sparing agents with more positive evidence for the latter.

Indexed as

AutoimmunityAdolescentAntibodies, Anti-IdiotypicAutoimmune DiseasesChildHumansImmunoglobulin GInflammationAntibodies, Anti-IdiotypicImmunoglobulin G

Identifiers

PMID27012661
PMCPMC4807566
OpenAlexW2303149295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.